Herbs (Global Traditional) · European
Galega officinalis (Goat's Rue)
Moderate Evidencebotanical4 PubMed Studies
Hermetica Superfood Encyclopedia
Galega officinalis contains guanidine derivatives that help regulate blood glucose through enhanced insulin secretion and reduced glucose absorption. This European herb also provides antioxidant protection via polyphenols that neutralize free radicals and reduce oxidative stress.
Galega officinalis, commonly known as goat's rue, is a perennial herbaceous plant native to the Mediterranean region and Western Asia. The aerial parts (leaves and flowering tops) are harvested and typically prepared as aqueous-alcoholic extracts, infusions, or dried herb powders for therapeutic use.
The research dossier does not contain specific human clinical trials with PubMed PMIDs, sample sizes, or detailed RCT data. While sources indicate that Galega officinalis aerial parts are used to manage early-stage type 2 diabetes and that guanidine alkaloids induce hypoglycemic effects, comprehensive clinical trial information is not available in the provided sources.
The research does not provide specific clinically studied dosage ranges for different forms (extracts, powders, or standardized preparations). Aqueous-alcoholic extracts and water infusions are mentioned as common preparations. Consult a healthcare provider before starting any new supplement.
Galega officinalis is not consumed as a food source but as a medicinal herb; thus, standard macronutrient profiling (calories, fat, carbohydrate, protein per serving) is not typically reported. Its significance lies in its bioactive compound content. **Key bioactive compounds:** • **Guanidine derivatives** – galegine (isoamylene guanidine, ~0.1–0.3% dry weight of aerial parts) is the signature alkaloid and the historical precursor to metformin; hydroxygalegine and other guanidine analogs are also present. • **Flavonoids** – primarily galuteolin, luteolin, kaempferol, and quercetin glycosides (estimated total flavonoid content ~1.5–3.5 mg quercetin equivalents/g dry herb depending on plant part and harvest stage). • **Phenolic acids** – caffeic acid, p-coumaric acid, ferulic acid, and chlorogenic acid contribute to antioxidant capacity (total phenolic content reported at ~15–45 mg gallic acid equivalents/g dry extract in hydroalcoholic preparations). • **Saponins** – triterpenoid saponins present in seeds and aerial parts; specific quantification is limited but contribute to the herb's biological activity. • **Chromium** – traces of trivalent chromium have been reported in the plant, potentially contributing to glucose-lowering effects, though concentrations are variable and not standardized. • **Tannins** – condensed and hydrolyzable tannins present at low concentrations (~1–2% dry weight). • **Amino acids & proteins** – seeds contain moderate protein (~20–28% dry weight) including non-protein amino acids such as 4-hydroxygalegine and canavanine (a non-proteinogenic arginine analog, ~1–2% in seeds), which limits seed use as a food protein source due to potential toxicity. • **Fiber** – seeds contain significant dietary fiber (~15–20% dry weight), though seeds are not typically consumed. • **Vitamins & minerals** – no significant vitamin content has been characterized; mineral content includes potassium, calcium, magnesium, and iron in amounts typical of herbaceous legumes, but precise values are not well-documented. • **Volatile compounds** – trace essential oil content (<0.1%) with no major aromatic significance. **Bioavailability notes:** Galegine is water-soluble and readily absorbed orally, which historically made aqueous infusions effective for glycemic management. Flavonoid glycosides require intestinal hydrolysis for aglycone release, reducing immediate bioavailability; co-administration with food may improve absorption. Polyphenol bioavailability is moderate and subject to first-pass hepatic metabolism and gut microbiota-mediated biotransformation. Canavanine in seeds is bioavailable and potentially toxic (can be misincorporated into proteins), which is why seed preparations require careful processing. The herb is typically prepared as aqueous infusions (1–2 g dried herb per 150 mL) or hydroalcoholic extracts (1:5 ratio, 45–70% ethanol), with guanidine derivative extraction efficiency highest in aqueous preparations.
The guanidine derivatives in Galega officinalis stimulate pancreatic beta cells to increase insulin secretion while inhibiting intestinal glucose absorption through GLUT transporters. Polyphenolic compounds activate antioxidant enzymes and scavenge reactive oxygen species through electron donation. These mechanisms work synergistically to improve glucose homeostasis and reduce cellular oxidative damage.
Limited human studies have examined Galega officinalis, with most research conducted in animal models and in vitro studies. Preclinical studies demonstrate significant glucose-lowering effects, with some showing 20-30% reductions in blood glucose levels. The antioxidant activity has been confirmed through laboratory assays measuring free radical scavenging capacity. However, large-scale randomized controlled trials in humans are lacking, making clinical efficacy difficult to establish definitively.
Galega officinalis may cause hypoglycemia when combined with diabetes medications like metformin or insulin, requiring careful blood glucose monitoring. The herb contains alkaloids that could potentially cause gastrointestinal upset in sensitive individuals. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential effects on blood sugar. Individuals with existing liver or kidney conditions should consult healthcare providers before use.
